|
|
Adjuvant systemic chemotherapy with cisplatin plus methotrexate (CM) versus methotrexate, vinblastine, epirubicin, and cisplatin (MVEC) for locally advanced bladder cancer: results of a randomised, multicenter phase III study in Germany
J. Lehmann, M. Retz, C. Weining, P. Albers, D. Frohneberg, T. Becker, P. J. Funke, P. Walz, S. Langbein, M. Schiller, K. Miller, S. Roth, H. G. Derigs, M. Stöckle
Journal of Urology* supplement 169 (2003) abstract 1306, p337 |
|